You are here

    • You are here:
    • Home > CRG researchers selected for EMBO Young Investigator programme

CRG researchers selected for EMBO Young Investigator programme

CRG researchers selected for EMBO Young Investigator programmeCRG researchers selected for EMBO Young Investigator programme

22
Nov
Tue, 22/11/2022 - 13:09

CRG researchers selected for EMBO Young Investigator programme

Lars Velten (right) and Arnau Sebe Pedros (left) have been recognised by the prestiguous organisation

CRG researchers Lars Velten and Arnau Sebe Pedros are two of 24 life scientists to be selected for this year’s EMBO Young Investigator Programme. The programme supports excellent group leaders who have been in independent positions for less than four years and have an excellent track record of scientific achievements.

This year’s Young Investigators are based in ten EMBC Member States as well as Singapore. Ten new EMBO Young Investigators are female (42%) and 14 are male (58%). The programme received 177 eligible applications, with a success rate of 14%. Dr. Velten and Dr. Sebe Pedros are the only two researchers based in Spain to be recognised by the programme this year.

Dr. Lars Velten is an experimental and computational biologist with a strong interest in the study of adult stem cells and gene regulation at a systems level. He develops novel methods rooted in single cell genomics and genetic screening, striving to tackle long-standing scientific questions through technological innovation.

Dr. Velten has been recognised by the EMBO Young Investigator programme for his work on studying the human hematopoietic system, which supplies our bodies with a trillion new blood cells per day, and constitutes one of the most sophisticated regenerative systems in biology. The ability to create this massive number of cells puts the system at high risk of accumulating mutations, which is mitigated by the presence of non-dividing long-term stem cells. The programme will help further his work to explore how lineage differentiation and activation of blood stem cells is regulated, and how blood stem cell identities are altered in leukaemia.

Dr. Arnau Sebe Pedros is an evolutionary biologist interested in the origin, diversity and evolution of cell types and genome regulatory mechanisms. He combines advanced single-cell and chromatin profiling technologies with comparative genomics to study cell type programs and genome regulation in diverse organisms, opening the way reconstruct how cell types and gene regulation evolve.

Dr. Sebe Pedros has been recognised by the EMBO Young Investigator programme for his continued efforts to expand our understanding of cell type and genome regulation from a phylogenetic perspective, Dr. Sebe Pedros hopes to reveal now just how these mechanisms evolved, but also identify shared principles of eukaryotic genome function.

“EMBO welcomes the new Young Investigators with a sense of excitement and pride,” says EMBO Director Fiona Watt. “One of the most remarkable things about this wonderful community is its diversity of expertise. Participation in the programme supports young group leaders at a critical phase of their careers, providing opportunities to develop their laboratories, learn from one another, and make lifelong connections within a supportive network.”

EMBO Young Investigators receive an award of 15,000 euros in the second year of their tenure and can apply for additional grants of up to 10,000 euros per year. They will receive financial and practical support for a period of four years, starting in January 2023.

They also benefit from a broad range of practical support, including networking opportunities for them and their lab members, mentoring by EMBO Members, training in areas such as leadership skills and responsible conduct of research, and access to core facilities at the European Molecular Biology Laboratory (EMBL). 

More information about the programme, including eligibility criteria and the application process, is available at: www.embo.org/funding/fellowships-grants-and-career-support/young-investi...

EMBO is an organization of more than 1,900 leading researchers that promotes excellence in the life sciences in Europe and beyond. The goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a research environment where scientists can achieve their best work.